Detalles de la búsqueda
1.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
Lancet Oncol
; 25(1): 99-107, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043558
2.
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 25(5): 563-571, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621400
3.
Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype.
PLoS Biol
; 19(9): e3001358, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520451
4.
Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images.
Eur J Nucl Med Mol Imaging
; 50(13): 4077-4086, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37550494
5.
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06.
Eur J Nucl Med Mol Imaging
; 50(13): 3970-3981, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563351
6.
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(11): 1389-1397, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261050
7.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Lancet
; 397(10276): 797-804, 2021 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581798
8.
Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images.
Eur J Nucl Med Mol Imaging
; 50(1): 67-79, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35976392
9.
Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups.
BJU Int
; 130 Suppl 3: 32-39, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35488182
10.
18F-Sodium Fluoride Positron Emission Tomography Activity Predicts the Development of New Coronary Artery Calcifications.
Arterioscler Thromb Vasc Biol
; 41(1): 534-541, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33267660
11.
The effect of Vitamin-K1 and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trial.
J Nucl Cardiol
; 29(4): 1855-1866, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33825140
12.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Lancet
; 395(10231): 1208-1216, 2020 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32209449
13.
ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901).
BJU Int
; 128(5): 642-651, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028967
14.
UpFrontPSMA: a randomized phase 2 study of sequential 177 Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol).
BJU Int
; 128(3): 331-342, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682320
15.
Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software.
J Nucl Cardiol
; 27(3): 952-961, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30684262
16.
Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
Dig Dis Sci
; 65(2): 647-657, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31440998
17.
Plasma lipoprotein(a) is associated with calcification activity of the thoracic aorta and aortic valve in statin naïve individuals with diabetes mellitus.
Eur J Clin Invest
; 54(5): e14167, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38265272
18.
TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603).
BJU Int
; 124 Suppl 1: 5-13, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31638341
19.
Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging.
Intern Med J
; 49(8): 1016-1022, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30667165
20.
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
BJU Int
; 122(5): 783-793, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29726071